Cargando…
Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
A hallmark of Alzheimer’s disease (AD) is the accumulation of oligomeric amyloid-β (Aβ) peptide, which may be primarily responsible for neuronal dysfunction. Insulin signaling provides a defense mechanism against oligomer-induced neuronal loss. We previously described the neuroprotective role of mat...
Autores principales: | Kaminari, Archontia, Giannakas, Nikolas, Tzinia, Athina, Tsilibary, Effie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429641/ https://www.ncbi.nlm.nih.gov/pubmed/28386117 http://dx.doi.org/10.1038/s41598-017-00794-5 |
Ejemplares similares
-
Elevation of MMP-9 Levels Promotes Epileptogenesis After Traumatic Brain Injury
por: Pijet, Barbara, et al.
Publicado: (2018) -
Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes
por: Gkogkas, Christos G., et al.
Publicado: (2014) -
The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer’s Disease In Vitro
por: Mavroidi, Barbara, et al.
Publicado: (2022) -
The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023) -
Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)